Pancreatic Cancer Research

ResearcherCity of HopeNo recent work listed

Amanda Kathleen Arrington

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8096-3373; OpenAlex author ID A5000812389. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper

Papers 5

  1. Survival after Margin-Positive Resection in the Era of Modern Chemotherapy for Pancreatic Cancer: Do Patients Still Benefit? Co-author DOI 10.1016/j.jamcollsurg.2021.02.020↗
  2. Pancreatic Cancer Lymph Node Resection Revisited: A Novel Calculation of Number of Lymph Nodes Required. Co-author DOI 10.1016/j.jamcollsurg.2018.12.031↗
  3. Pancreatic Cancer Lymph Node Status: An Unsolved Problem that Impacts Recommendation Despite Guidelines: In reply to Hyer and colleagues. Co-author DOI 10.1016/j.jamcollsurg.2019.03.003↗
  4. Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells. First author DOI 10.1007/s12307-013-0130-6↗
  5. Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy. First author DOI 10.1016/j.amjsurg.2012.02.016↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Taylor Sohn Riall · 3 shared papers, 2019–2021 · strength 0.50
  2. Mohammad R. Khreiss · 1 shared paper, 2021 · strength 0.16
  3. Eileen L. Heinrich · 1 shared paper, 2013 · strength 0.04
  4. Joseph Kim · 1 shared paper, 2013 · strength 0.04
  5. Selwyn Maurice Vickers · 1 shared paper, 2012 · strength 0.03
  6. Julia Davydova · 1 shared paper, 2012 · strength 0.03
  7. Leonard Armstrong · 1 shared paper, 2012 · strength 0.03
  8. Masato Yamamoto · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.